AGREEMENT
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act
of 1934, as amended, the undersigned hereby agree that this Amendment to
Schedule 13D dated June 16, 2000 relating to the Common Stock, no par value, of
Cellegy Pharmaceuticals, Inc., and such other amendments as may be filed by them
hereafter, are being filed with the Securities and Exchange Commission on behalf
of each of them.
June 22, 2000 By:/s/ Xxxxxx X. Xxxxx
-------------------
Xxxxxx X. Xxxxx
By:/s/ Xxxxxx X. Xxxxx
-------------------
Xxxxxx X. Xxxxx
By:/s/ Xxxxx X. Xxxxx
-------------------
Xxxxx X. Xxxxx
By:/s/ Xxxxxx X. Xxxxx
-------------------
Xxxxxx X. Xxxxx
By:/s/ Xxxxxx X. Xxxxx
-------------------
Xxxxxx X. Xxxxx
By:/s/ Xxxxx X. Xxxxx
-------------------
Xxxxx X. Xxxxx